BackBG Medicine Overview

BG Medicine Receivables

Track BG Medicine's receivables ($180K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$181000.00
↑ 4.02% YoYΔ $7000.00 vs prior year quarter

Peer trimmed avg / median

Loading

BG Medicine Receivables History

Loading

BG Medicine vs. peers: Receivables Comparison

Loading

BG Medicine Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BG Medicine (BGMD) FAQ

As of the most recent data (December 2015), BGMD shows a receivables of $180K. That compares with $170K in the prior-year period — up 4.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BGMD's receivables is now $180K (was $170K) — a 4.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BG Medicine is outperforming or lagging.

Tracking BGMD's receivables over time shows whether BG Medicine is scaling, shrinking, or reshaping that part of the business. The current reading is $180K That compares with $170K in the prior-year period — up 4.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has BG Medicine's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $180K) with ownership activity and broader fundamentals.